Cardinal Health (CAH) Stock Movement Summary Cardinal Health shares rallied following strong financial results and multiple guidance increases. The company reported stronger-than-expected profit and revenue in its fiscal second quarter, with adjusted EPS of $2.63 beating analyst consensus by 11.2%. Sales rose 18.8% year-over-year to $65.63 billion. The company raised its full-year earnings guidance for the second time, citing broad-based growth across all operating segments and sustained momentum in pharmaceutical distribution. CEO Jason Hollar attributed the performance to resilient healthcare utilization and improved operational efficiency. Cardinal Health also boosted its share buyback program. Multiple analysts raised price targets, including Morgan Stanley (to $255 from $245) and Citigroup, which turned bullish on the company's specialist assets. The stock gained 9.83% to $227.18 on the trading day, outperforming broader market indices.
Read full analysisCardinal Health (CAH) Stock Movement Summary Cardinal Health shares rallied following strong financial results and multiple guidance increases. The company reported stronger-than-expected profit and revenue in its fiscal second quarter, with adjusted EPS of $2.63 beating analyst consensus by 11.2%. Sales rose 18.8% year-over-year to $65.63 billion. The company raised its full-year earnings guidance for the second time, citing broad-based growth across all operating segments and sustained momentum in pharmaceutical distribution. CEO Jason Hollar attributed the performance to resilient healthcare utilization and improved operational efficiency. Cardinal Health also boosted its share buyback program. Multiple analysts raised price targets, including Morgan Stanley (to $255 from $245) and Citigroup, which turned bullish on the company's specialist assets. The stock gained 9.83% to $227.18 on the trading day, outperforming broader market indices.
Cardinal Health Inc. (CAH) is a publicly traded company in the Healthcare sector.